Endometrial cancer: Utility of diffusion-weighted magnetic resonance imaging with background body signal suppression at 3T

Journal of Magnetic Resonance Imaging

Volumn 37, Issue 5, 2013, Pages 1151-1159

  Seo, Jung Min ^a   Kim, Chan Kyo ^a   Choi, Dongil ^a   Kwan Park, Byung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

comparative studies; diffusion weighted imaging; endometrial carcinoma; magnetic resonance imaging; staging

Indexed keywords

ARTICLE; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; ALGORITHMS; ARTIFACTS; DIFFUSION MAGNETIC RESONANCE IMAGING; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MIDDLE AGED; NEOPLASM INVASIVENESS; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE;

EID: 84876469388     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23900     Document Type: Article

References (36)

1. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I,. Endometrial cancer. Lancet 2005; 366: 491-505.
2. Berman M, Ballon S, Lagasse L, Watring W,. Prognosis and treatment of endometrial cancer. Am J Obstet Gynecol 1980; 136: 679.
3. Larson DM, Connor GP, Broste SK, Krawisz BR, Johnson KK,. Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 1996; 88: 394.
4. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB,. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer 1987; 60: 2035-2041.
5. Goff BA, Rice LW,. Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol 1990; 38: 46-48.
6. Manfredi R, Mirk P, Maresca G, et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 2004; 231: 372.
7. Hricak H, Rubinstein L, Gherman G, Karstaedt N,. MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study. Radiology 1991; 179: 829.
8. Sironi S, Colombo E, Villa G, et al. Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging. Radiology 1992; 185: 207.
9. Kinkel K, Kaji Y, Yu KK, et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 1999; 212: 711-718.
10. Yamashita Y, Harada M, Sawada T, Takahashi M, Miyazaki K, Okamura H,. Normal uterus and FIGO stage I endometrial carcinoma: dynamic gadolinium-enhanced MR imaging. Radiology 1993; 186: 495.
11. Seki H, Kimura M, Sakai K,. Myometrial invasion of endometrial carcinoma: assessment with dynamic MR and contrast-enhanced T1-weighted images. Clin Radiol 1997; 52: 18-23.
12. Savci G, Ozyaman T, Tutar M, Bilgin T, Erol O, Tuncel E,. Assessment of depth of myometrial invasion by endometrial carcinoma: comparison of T2-weighted SE and contrast-enhanced dynamic GRE MR imaging. Eur Radiol 1998; 8: 218-223.
13. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007; 243: 148-157.
14. Fujii S, Matsusue E, Kigawa J, et al. Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results. Eur Radiol 2008; 18: 384-389.
15. Shen SH, Chiou YY, Wang JH, et al. Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. Am J Roentgenol 2008; 190: 481.
16. Rechichi G, Galimberti S, Signorelli M, Perego P, Valsecchi MG, Sironi S,. Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T. Eur Radiol 2010; 20: 754-762.
17. Koyama T, Togashi K,. Functional MR imaging of the female pelvis. J Magn Reson Imaging 2007; 25: 1101-1112.
18. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M,. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004; 22: 275-282.
19. Komori T, Narabayashi I, Matsumura K, et al. 2-[Fluorine-18]-fluoro-2- deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. Ann Nucl Med 2007; 21: 209-215.
20. Murtz P, Krautmacher C, Traber F, Gieseke J, Schild HH, Willinek WA,. Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla. Eur Radiol 2007; 17: 3031-3037.
21. Pecorelli S,. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009; 105: 103-104.
22. Takahashi S, Murakami T, Narumi Y, et al. Preoperative staging of endometrial carcinoma: diagnostic effect of T2-weighted fast spin-echo MR imaging. Radiology 1998; 206: 539.
23. Utsunomiya D, Notsute S, Hayashida Y, et al. Endometrial carcinoma in adenomyosis: assessment of myometrial invasion on T2-weighted spin-echo and gadolinium-enhanced T1-weighted images. Am J Roentgenol 2004; 182: 399.
24. Lin G, Ng KK, Chang CJ, et al. Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging-initial experience. Radiology 2009; 250: 784.
25. Rechichi G, Galimberti S, Signorelli M, et al. Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases. AJR Am J Roentgenol 2011; 197: 256-262.
26. Kwee TC, Takahara T, Ochiai R, Nievelstein RAJ, Luijten PR,. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 2008; 18: 1937-1952.
27. Namimoto T, Awai K, Nakaura T, Yanaga Y, Hirai T, Yamashita Y,. Role of diffusion-weighted imaging in the diagnosis of gynecological diseases. Eur Radiol 2009; 19: 745-760.
28. Tamai K, Koyama T, Saga T, et al. Diffusion weighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging 2007; 26: 682-687.
29. Inada Y, Matsuki M, Nakai G, et al. Body diffusion-weighted MR imaging of uterine endometrial cancer: is it helpful in the detection of cancer in nonenhanced MR imaging? Eur J Radiol 2009; 70: 122-127.
30. Cao K, Gao M, Sun YS, et al. Apparent diffusion coefficient of diffusion weighted MRI in endometrial carcinoma-Relationship with local invasiveness. Eur J Radiol 2012; 81: 1926-1930.
31. Sato C, Naganawa S, Nakamura T, et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 2005; 21: 258-262.
32. Naganawa S, Sato C, Kumada H, Ishigaki T, Miura S, Takizawa O,. Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 2005; 15: 71-78.
33. Naganawa S, Kawai H, Fukatsu H, Sakurai Y, Aoki I, Miura S,. Diffusion-weighted imaging of the liver: technical challenges and prospects for the future. Magn Reson Med Sci 2005; 4: 175-186.
34. Hosonuma T, Tozaki M, Ichiba N, et al. Clinical usefulness of diffusion-weighted imaging using low and high b-values to detect rectal cancer. Magn Reson Med Sci 2006; 5: 173.
35. Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC, Miller DS,. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 1991; 78: 63-69.
36. Kwee TC, Takahara T, Luijten PR, Nievelstein RAJ,. ADC measurements of lymph nodes: inter- and intra-observer reproducibility study and an overview of the literature. Eur J Radiol 2010; 75: 215-220.